Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07351422

Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis

This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition. To achieve this, two separate questionnaires will be conducted: one for patients and one for physicians.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Takayasu Arteritis Aortic Arch Syndromes Aortic Diseases Arteritis Cardiovascular Diseases Skin Diseases Skin Diseases, Vascular Skin and Connective Tissue Diseases Takayasu Arteritis (TAK) Vascular Diseases Vasculitis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

This study aims to investigate the experiences and perceptions of patients with Takayasu arteritis regarding their disease, as well as the perspectives of physicians regarding the management and treatment of these patients.

Patients with TAK will be invited to complete an anonymous online (Online Surveys) questionnaire, which will take approximately 25 minutes and will consist of multiple-choice and short-answer questions. The questionnaire will ask about their experience with the condition, symptoms, treatments they have received, and any concerns or priorities they have regarding their care.

Physicians who treat TAK will also be invited to complete a separate online questionnaire, taking around 15 minutes and also consisting of multiple-choice and short-answer questions. This will explore how they diagnose and manage TAK, their choice of treatments, and any challenges they face in treating the condition

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

For the patient questionnaire:

  • Age ≥ 18 years
  • A formal diagnosis of TAK

For the physician questionnaire

  • A physician involved in the management/decision-making for patients diagnosed with TAK

Exclusion criteria

For the patient questionnaire:

  • Age < 18 years
  • Lack of a formal diagnosis of TAK
  • Patients without mental capacity or willingness to provide informed consent
  • Not UK based

For the physician questionnaire

  • Not involved in the management/ decision making for patients diagnosed with TAK
  • Not willing to take part
  • Not UK based

Treatment and study plan

Questionnaire

Other

An online annoymous questionnaire consisting of short-answer and multiple-choice questions

Primary outcomes

  1. Patient Perspective

    Time frame: Day 1

    To understand the lived experiences of individuals with TAK, including their symptoms, health status post-diagnosis, treatment priorities, and concerns.

    The questionnaire covers the following topics:

    • Basic background information
    • Living with Takayasu arteritis
    • Changes to health since diagnosis
    • Physical activity and exercise habits- measured by the International Physical Activity Questionnaire (IPAQ)
    • Smoking history
    • Mental well-being- measured by the EQ-5D instrument
    • Nutrition and diet
    • Personal views and priorities on management

  2. Physician Perspective

    Time frame: Day 1

    To evaluate current clinical management strategies for TAK, identify treatment priorities, and highlight areas of unmet need in clinical practice.

    The physician questionnaire covers the following topics:

    • Clinical background and experience with TAK patients
    • Diagnostic and treatment strategies for TAK
    • Consideration of cardiovascular disease risk in TAK management
    • Physician priorities and unmet needs of management

Study contacts

Contact information is provided by the study sponsor or research team.

Alexandra Armstrong

CONTACT

[email protected]

+447445695898

Sponsors and collaborators

Lead sponsor

University of Edinburgh

Other

Registry information

Acronym: TAK-IMPACT

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Jan 20, 2026
Registry last updated
Jan 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.